Evaluating Patients' Unmet Needs in Hidradenitis Suppurativa: results from the Global VOICE project

Acne

Improvement in Hidradenitis Suppurativa and Quality of Life in Patients Treated With Adalimumab: Real-World Results From the HARMONY Study

J Eur Acad Dermatol Venereol

Hafner A, Ghislain PD, Kovács R, Batchelor R, Katoulis AC, Kirby B, Banayan H, Schonbrun M

doi: 10.1111/jdv.17551

Acne

Hidradenitis Suppurativa Odor and Drainage Scale: A Novel Method for Evaluating Odor and Drainage in Patients with Hidradenitis Suppurativa

Br J Dermatol

Machado MO, Lu JD, Brar R, Kirby J, Garg A, Lowes M, Piguet V, Alavi A

doi: 10.1111/bjd.19686

Acne

Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study

J Am Acad Dermatol.

Zouboulis CC, Okun MM, Prens EP, Gniadecki R, Foley PA, Lynde C, Weisman J, Gu Y, Williams DA, Jemec GBE

doi: 10.1016/j.jaad.2018.05.040.

COMMENTED

Acne

North American Clinical Management Guidelines for Hidradenitis Suppurativa: a Publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Part I: Diagnosis, Evaluation, and the use of Complementary and Procedural Management

J Am Acad Dermatol.

Alikhan A, Sayed C, Alavi A, Alhusayen R, Brasasard A, Burkhart C, Crowell K, Eisen D, Gottlieb A, Hamzavi I, Hazen P, Jaleel T, Kimball A, Kirby J, Lowes MA, Micheletti R, Miller A, Naik HB, Orgill D, Poulin Y

doi: 10.1016/j.jaad.2019.02.067.

Acne

Baseline patient-reported outcomes from UNITE: an observational, international, multicentre registry to evaluate hidradenitis suppurativa in clinical practice

J Eur Acad Dermatol Venereol.

Kimball AB, Crowley JJ, Papp K, Calimlim B, Duan Y, Fleischer AB, Sobell J

doi: 10.1111/jdv.16132.

Acne

Apremilast for moderate hidradenitis suppurativa: Results of a randomized controlled trial

J Am Acad Dermatol.

Vossen ARJV, van Doorn MBA, van der Zee HH, Prens EP

doi: 10.1016/j.jaad.2018.06.046.

Psoriatic ArthritisSpinal Disorders

Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis

Rheumatology (Oxford).

Michelsen B, Ørnbjerg LM, Kvien TK, Pavelka K, Nissen MJ, Nordström D, Santos MJ, Koca SS, Askling J, Rotar Z, Gudbjornsson B, Codreanu C, Loft AG, Kristianslund EK, Mann HF, Ciurea A, Eklund KK, Vieira-Sousa E, Yazici A, Jacobsson L, Tomšič M, Löve TJ, Ionescu R, van der Horst-Bruinsma IE, Iannone F, Pombo-Suarez M, Jones GT, Hyldstrup LH, Krogh NS, Hetland ML, Østergaard M

doi: 10.1093/rheumatology/kez656.

Rheumatoid Arthritis

Assessments of the unmet need in the management of patients with rheumatoid arthritis: analyses from the NOR-DMARD registry

Rheumatology (Oxford).

Olsen IC, Lie E, Vasilescu R, Wallenstein G, Strengholt S, Kvien TK

doi: 10.1093/rheumatology/key338.

COMMENTED

Acne

Adalimumab Medium-Term Dosing Strategy in Moderate-to-Severe Hidradenitis Suppurativa: Integrated Results from the Phase 3, Randomized, Placebo-Controlled, PIONEER Trials

Br J Dermatol.

Jemec GBE, Okun MM, Forman SB, Gulliver WPF, Prens EP, Mrowietz U, Armstrong AW, Geng Z, Gu Y, Williams DA, Teixeira HD, Kimball AB

doi: 10.1111/bjd.17919.

Related content

Improvement in Hidradenitis Suppurativa and Quality of Life in Patients Treated With Adalimumab: Real-World Results From the HARMONY Study

Hidradenitis Suppurativa Odor and Drainage Scale: A Novel Method for Evaluating Odor and Drainage in Patients with Hidradenitis Suppurativa

Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study

North American Clinical Management Guidelines for Hidradenitis Suppurativa: a Publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Part I: Diagnosis, Evaluation, and the use of Complementary and Procedural Management

Baseline patient-reported outcomes from UNITE: an observational, international, multicentre registry to evaluate hidradenitis suppurativa in clinical practice

Apremilast for moderate hidradenitis suppurativa: Results of a randomized controlled trial

Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis

Assessments of the unmet need in the management of patients with rheumatoid arthritis: analyses from the NOR-DMARD registry

Adalimumab Medium-Term Dosing Strategy in Moderate-to-Severe Hidradenitis Suppurativa: Integrated Results from the Phase 3, Randomized, Placebo-Controlled, PIONEER Trials